BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25095499)

  • 1. Fifteen years later: main lessons from composite tissue allografts.
    Dubernard JM; Sirigu A; Seulin C; Morelon E; Petruzzo P
    Clin Transpl; 2013; ():113-9. PubMed ID: 25095499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel immunosuppressive strategies for composite tissue allografts.
    Gupta A; Kumer S; Kaplan B
    Curr Opin Organ Transplant; 2014 Dec; 19(6):552-7. PubMed ID: 25333828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts.
    Hautz T; Zelger BG; Nasr IW; Mundinger GS; Barth RN; Rodriguez ED; Brandacher G; Weissenbacher A; Zelger B; Cavadas P; Margreiter R; Lee WP; Pratschke J; Lakkis FG; Schneeberger S
    Transpl Int; 2014 Sep; 27(9):966-76. PubMed ID: 24853399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study.
    Fries CA; Lawson SD; Wang LC; Slaughter KV; Vemula PK; Dhayani A; Joshi N; Karp JM; Rickard RF; Gorantla VS; Davis MR
    PLoS One; 2019; 14(1):e0210914. PubMed ID: 30677062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges.
    Honeyman C; Stark H; Wang HC; Hester J; Issa F; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):711-717. PubMed ID: 33436335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.
    Friedman O; Carmel N; Sela M; Abu Jabal A; Inbal A; Ben Hamou M; Krelin Y; Gur E; Shani N
    PLoS One; 2017; 12(7):e0181507. PubMed ID: 28746417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
    Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composite tissue transplantation.
    Brandacher G
    Methods Mol Biol; 2013; 1034():103-15. PubMed ID: 23775733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Rejection Rates in Vascularized Composite Allografts: A Systematic Review of Case Reports.
    Van Dieren L; Tawa P; Coppens M; Naenen L; Dogan O; Quisenaerts T; Lancia HH; Oubari H; Dabi Y; De Fré M; Thiessen Ef F; Cetrulo CL; Lellouch AG
    J Surg Res; 2024 Jun; 298():137-148. PubMed ID: 38603944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Registry on Hand and Composite Tissue allotransplantation.
    Petruzzo P; Dubernard JM
    Clin Transpl; 2011; ():247-53. PubMed ID: 22755418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Multifunctional Outcome and Risks of Face Vascularized Composite Allotransplantation.
    Roche NA; Blondeel PN; Vermeersch HF; Peeters PC; Lemmens GM; De Cubber J; De Letter M; Van Lierde K
    J Craniofac Surg; 2015 Oct; 26(7):2038-46. PubMed ID: 26468783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological issues in clinical composite tissue allotransplantation: where do we stand today?
    Morelon E; Kanitakis J; Petruzzo P
    Transplantation; 2012 May; 93(9):855-9. PubMed ID: 22538449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory oversight in the United States of vascularized composite allografts.
    Glazier AK
    Transpl Int; 2016 Jun; 29(6):682-5. PubMed ID: 26284312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scabies in a bilateral hand allograft recipient: An additional mimicker of acute skin rejection in vascularized composite allotransplantation.
    Kanitakis J; Morelon E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28211139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunology of composite tissue transplantation.
    Pidwell DJ; Burns C
    Clin Plast Surg; 2007 Apr; 34(2):303-17, x. PubMed ID: 17418679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?
    Sicard A; Kanitakis J; Dubois V; Morelon E; Thaunat O
    Transplantation; 2020 Oct; 104(10):2003-2010. PubMed ID: 32039965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.